Core Insights - Molina's quarterly earnings were reported at $1.84 per share, significantly missing the Zacks Consensus Estimate of $3.97 per share, representing an earnings surprise of -53.65% [1] - The company posted revenues of $11.48 billion for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 5.28% and showing an increase from $10.34 billion year-over-year [2] - Molina's stock has underperformed, losing approximately 32.4% since the beginning of the year, while the S&P 500 has gained 14.5% [3] Earnings Performance - Over the last four quarters, Molina has surpassed consensus EPS estimates only once [2] - The current consensus EPS estimate for the upcoming quarter is $3.38, with expected revenues of $11.07 billion, and for the current fiscal year, the EPS estimate is $18.87 on revenues of $44.54 billion [7] Market Outlook - The company's earnings outlook is crucial for investors, as it reflects current consensus expectations and any recent changes [4] - The trend of estimate revisions for Molina was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell), indicating expected underperformance in the near future [6] - The Medical - HMOs industry, to which Molina belongs, is currently ranked in the top 39% of over 250 Zacks industries, suggesting a favorable industry outlook [8] Competitor Insights - Cigna, another company in the same industry, is expected to report quarterly earnings of $7.70 per share, reflecting a year-over-year increase of 2.5%, with revenues projected at $67.19 billion, up 5.5% from the previous year [9]
Molina (MOH) Q3 Earnings Lag Estimates